CD4 and neoplasm: We took advantage of the ex-vivo re-stimulation assay developed in our laboratory to test the presence and the quality (i.e., the cytokine profile) of anti-viral and anti-tumor recall CD4+ T cell responses in healthy donors and neoplastic patients [16], [18], [19].